NM_001370466.1:c.785A>G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001370466.1(NOD2):​c.785A>G​(p.Asn262Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0058 in 1,614,044 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0054 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0058 ( 44 hom. )

Consequence

NOD2
NM_001370466.1 missense

Scores

5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:9

Conservation

PhyloP100: 4.18

Publications

31 publications found
Variant links:
Genes affected
NOD2 (HGNC:5331): (nucleotide binding oligomerization domain containing 2) This gene is a member of the Nod1/Apaf-1 family and encodes a protein with two caspase recruitment (CARD) domains and six leucine-rich repeats (LRRs). The protein is primarily expressed in the peripheral blood leukocytes. It plays a role in the immune response to intracellular bacterial lipopolysaccharides (LPS) by recognizing the muramyl dipeptide (MDP) derived from them and activating the NFKB protein. Mutations in this gene have been associated with Crohn disease and Blau syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jun 2014]
NOD2 Gene-Disease associations (from GenCC):
  • Blau syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Genomics England PanelApp, G2P, Illumina, Labcorp Genetics (formerly Invitae)
  • inflammatory bowel disease 1
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003724575).
BP6
Variant 16-50710777-A-G is Benign according to our data. Variant chr16-50710777-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 319440.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00541 (824/152214) while in subpopulation NFE AF = 0.00747 (508/67984). AF 95% confidence interval is 0.00693. There are 4 homozygotes in GnomAd4. There are 352 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 824 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOD2NM_001370466.1 linkc.785A>G p.Asn262Ser missense_variant Exon 4 of 12 ENST00000647318.2 NP_001357395.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOD2ENST00000647318.2 linkc.785A>G p.Asn262Ser missense_variant Exon 4 of 12 NM_001370466.1 ENSP00000495993.1 Q9HC29-2

Frequencies

GnomAD3 genomes
AF:
0.00536
AC:
815
AN:
152096
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00466
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00596
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000566
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00747
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00440
AC:
1104
AN:
250986
AF XY:
0.00428
show subpopulations
Gnomad AFR exome
AF:
0.00443
Gnomad AMR exome
AF:
0.00579
Gnomad ASJ exome
AF:
0.000894
Gnomad EAS exome
AF:
0.000544
Gnomad FIN exome
AF:
0.000883
Gnomad NFE exome
AF:
0.00677
Gnomad OTH exome
AF:
0.00392
GnomAD4 exome
AF:
0.00584
AC:
8537
AN:
1461830
Hom.:
44
Cov.:
40
AF XY:
0.00571
AC XY:
4153
AN XY:
727212
show subpopulations
African (AFR)
AF:
0.00496
AC:
166
AN:
33478
American (AMR)
AF:
0.00599
AC:
268
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00153
AC:
40
AN:
26136
East Asian (EAS)
AF:
0.000277
AC:
11
AN:
39700
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86256
European-Finnish (FIN)
AF:
0.000862
AC:
46
AN:
53370
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.00692
AC:
7697
AN:
1112006
Other (OTH)
AF:
0.00485
AC:
293
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
592
1184
1776
2368
2960
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00541
AC:
824
AN:
152214
Hom.:
4
Cov.:
33
AF XY:
0.00473
AC XY:
352
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.00486
AC:
202
AN:
41564
American (AMR)
AF:
0.00595
AC:
91
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3464
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5164
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
0.000566
AC:
6
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00747
AC:
508
AN:
67984
Other (OTH)
AF:
0.00521
AC:
11
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
37
74
111
148
185
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00654
Hom.:
12
Bravo
AF:
0.00584
TwinsUK
AF:
0.00593
AC:
22
ALSPAC
AF:
0.00675
AC:
26
ESP6500AA
AF:
0.00409
AC:
18
ESP6500EA
AF:
0.00628
AC:
54
ExAC
AF:
0.00425
AC:
516
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00638
EpiControl
AF:
0.00688

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NOD2: BS1, BS2 -

Sep 04, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autoinflammatory syndrome Uncertain:1
Mar 21, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Regional enteritis;C5201146:Blau syndrome Benign:1
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inflammatory bowel disease 1 Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

NOD2-related disorder Benign:1
Apr 14, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Blau syndrome Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
14
DANN
Benign
0.68
DEOGEN2
Benign
0.29
.;T
Eigen
Benign
-0.51
Eigen_PC
Benign
-0.48
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.75
T;T
MetaRNN
Benign
0.0037
T;T
MetaSVM
Benign
-0.86
T
MutationAssessor
Uncertain
2.9
.;M
PhyloP100
4.2
PrimateAI
Uncertain
0.52
T
PROVEAN
Uncertain
-2.4
.;N
REVEL
Benign
0.22
Sift
Benign
0.057
.;T
Sift4G
Uncertain
0.053
.;T
Polyphen
0.62
P;B
Vest4
0.28
MVP
0.71
MPC
0.13
ClinPred
0.036
T
GERP RS
4.5
Varity_R
0.076
gMVP
0.51
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5743271; hg19: chr16-50744688; COSMIC: COSV100319028; COSMIC: COSV100319028; API